the sun malaysia ipaper logo 150x150
Friday, July 3, 2026
28.6 C
Kuala Lumpur
the sun malaysia ipaper logo 150x150

King, Queen to undertake state visit to Singapore

KUALA LUMPUR: His Majesty Sultan Ibrahim, King of Malaysia and Her Majesty Raja Zarith Sofiah, Queen of Malaysia, will undertake a State Visit to Singapore on 6 and 7 May 2024 at the invitation of the republic’s President Tharman Shanmugaratnam.

The Foreign Ministry in a statement today said this will be His Majesty’s maiden State Visit since ascending the throne on 31 January 2024

Wisma Putra said Their Majesties will be accompanied by Transport Minister Anthony Loke Siew Fook and Malaysian High Commissioner to Singapore Datuk Dr Azfar Mohamad Mustafar.

“During the State Visit, Their Majesties will be accorded a State Welcome at The Istana, Singapore, followed by a meeting with President Tharman Shanmugaratnam. The President of Singapore will also host a State Banquet in honour of Their Majesties.

“His Majesty Sultan Ibrahim has also consented to grant audiences to Prime Minister of Singapore Lee Hsien Loong and Deputy Prime Minister Lawrence Wong,“ said the statement.

It added that His Majesty is also scheduled to visit Singapore’s Parliament and inspect the progress of the Johor Bahru-Singapore Rapid Transit System Link (RTS Link) project

According to the statement, this State Visit symbolises the long-standing and dynamic bilateral relations between Malaysia and Singapore, reaffirming a shared commitment to deepen and diversify cooperation between the two countries.

“For more than a decade, Malaysia and Singapore have been each other’s second largest global trading partner and the largest among ASEAN countries. In 2023, total trade between the two countries was valued at RM363.13 billion (US$79.60 billion),“ it said.

STAY AHEAD OF THE CURVE

Join our community for instant updates and exclusive content.

Join Telegram Channel

Related


spot_img

Latest News

Bora Pharmaceuticals Completes Acquisition of MacroGenics’ Rockville Manufacturing Operations

TAIPEI, TAIWAN - Media OutReach Newswire - 2 July 2026 - Bora Pharmaceuticals Co., Ltd. ("Bora" or "Bora Group"; TWSE: 6472; OTCQX: BORAY) today announced the completion of its acquisition of the GMP manufacturing operations of MacroGenics, Inc. (NASDAQ: MGNX) including its biologics drug substance facility in Rockville, Maryland and an associated warehousing center in Frederick, Maryland, for total consideration of US $122.5 million through its wholly owned subsidiary Bora Biologics USA, LLC.. Upon closing, Bora signed a long-term CDMO Service Agreement with MacroGenics.

Most Viewed

spot_img
WC26

World Cup 2026

Updates, Fixtures, Results & Standings